In the pancreas, they enhance glucose-dependent insulin secretion while suppressing glucagon release, improving glycemic control
In the increasingly competitive GLP-1 market, Novo Nordisk has continued to explore and expand the boundaries of Semaglutide's indications, with multiple clinical launches in NASH, AD, HFpEF, DR, PAD, and other indications
4 Your GP should monitor your blood pressure as you lose weight, in case your ramipril dose needs reducing
Brello Health is a telehealth service that provides access to licensed clinicians who evaluate each patient for eligibility
These symptoms may indicate inadequate diabetes control and warrant blood glucose monitoring and possible medication adjustment